Variations in virus tails may help predict which phages kill more bacterial strains

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-23T17:21:01.441Z • Permanent link

Scientists at the University of California, Los Angeles (UCLA), have made a groundbreaking discovery in the field of bacteriophage research, shedding new light on the elusive world of virus-bacteria interactions. Led by Dr. Ziv Bar-Joseph, a renowned expert in computational biology, the team has been studying the genetic variations of phages that infect a range of bacterial strains. Their findings suggest that subtle changes in the tail region of these viruses may hold the key to predicting which phages are most effective against specific bacterial pathogens.

The research was conducted in collaboration with Dr. Jacob Whiteley, a postdoctoral researcher at UCLA, who worked alongside Dr. Bar-Joseph to develop a computational framework for analyzing phage genomics. Their approach involved analyzing the genetic sequences of over 100 phages that infect E. coli, a common bacterium found in the human gut. By comparing the genetic variations in the tail region of these phages, the researchers identified distinct patterns that correlated with the ability of each phage to kill specific bacterial strains.

The study's findings have significant implications for the development of new phage-based therapies, particularly in the context of antibiotic-resistant infections. According to Dr. Bar-Joseph, "Our research provides a new tool for identifying phages that are most effective against specific bacterial strains, which could lead to the development of more targeted and effective treatments for infections that are resistant to traditional antibiotics.

The implications of this research extend beyond the scientific community, with potential applications in various industries, including pharmaceuticals and biotechnology. Companies like Intrexon, a leading developer of phage-based therapies, are already exploring the use of these viruses to combat antibiotic-resistant infections. The research's findings could also inform policy decisions related to the regulation of phage-based therapies, with implications for public health and the development of new treatment options.

The study's results have also sparked interest among researchers in the field of synthetic biology, who are exploring the use of phages as a tool for engineering new biological systems. According to Dr. Whiteley, "Our work provides a new framework for understanding the complex interactions between phages and bacteria, which could lead to the development of new tools for synthetic biology applications.

The discovery of new phage-based therapies has been a long time coming, with researchers having been studying these viruses for decades. However, the field has been hampered by the lack of effective tools for identifying and characterizing phages that are most effective against specific bacterial strains. In recent years, advances in computational biology and genomics have provided new insights into the genetic and molecular mechanisms underlying phage-bacteria interactions, paving the way for the development of more targeted and effective therapies.